Doxycycline in Type II Diabetes

Recruiting now · Phase 1/Phase 2

Conditions studied: Diabetes Mellitus, Type 2

In brief

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disease characterized by hyperglycemia, weight loss, and cardio-metabolic complications. T2DM develops due to the progression of insulin resistance (IR), impairment of insulin insensitivity, and failure of the pancreatic β-cells to release sufficient amount of insulin in response to glucose burden

Key facts

Study ID

NCT06329882

Run by

Mostafa Bahaa

People needed

60

Starts

2024-03-30

Expected to finish

2026-04-20

Last updated by the study team

2025-04-04

Who can join

Age: 40 and older, up to 60. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Male or female sex more than 40 years old Newly diagnosed type II diabetes. HbA1c more than 6.5

You may not qualify if…

• Patient with chronic kidney disease, hepatic disorders, mental and psychiatric disorders, pregnancy, and lactation

Where it is running

• Tanta Unuversity — Tanta, Egypt (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.